Top

Category: Vaccines


FDA, Industry, Regulations, Vaccines

FDA Tells Vaccine Makers to Target New COVID Variant for Fall

June 14, 2024

Via: Drugs.com

COVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the U.S. Food and Drug Administration announced Thursday. It’s a turnaround for the agency: […]


FDA, Industry, Regulations, Vaccines

FDA Gives Nod to RSV Vaccine for People in Their 50s

June 10, 2024

Via: Drugs.com

The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. Drugmaker GSK’s Arexvy vaccine, […]


FDA, Industry, Regulations, Vaccines

FDA advisers back updating COVID shots to target JN.1 virus family

June 6, 2024

Via: Biopharma Dive

A group of advisers to the Food and Drug Administration on Wednesday unanimously recommended that COVID-19 vaccines be updated to cover coronavirus strains with a family known as JN.1 ahead of the fall. The committee, which had originally been scheduled […]


Industry, Vaccines

U.S. Will Make Millions of Bird Flu Vaccines This Summer

June 3, 2024

Via: Drugs.com

As the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million doses of flu vaccine are now being prepared for possible use in humans. Since the outbreak in livestock began this spring, bird […]


FDA, Industry, Regulations, Vaccines

Moderna wins FDA approval for RSV vaccine

May 31, 2024

Via: Biopharma Dive

The Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial virus, clearing a shot from biotechnology company Moderna one year after granting a green light to vaccines from GSK and Pfizer. The vaccine, dubbed mResvia, is […]


Industry, Vaccines

Vaccines Will Be Best Defense Against Bird Flu, Experts Say

May 29, 2024

Via: Drugs.com

Humanity’s best protection against bird flu will be the development of effective vaccines, a new study says. The H5N1 avian flu has been raging through cattle and poultry in the United States, increasing fears that the virus will make the […]


Industry, Vaccines

Repeat COVID Vaccination Could Shield Against Wide Range of Viruses

May 21, 2024

Via: Drugs.com

Powerful COVID vaccines could be setting people’s immune systems up to successfully fight off not just future COVID variants, but other types of coronaviruses as well, a new study shows. People repeatedly vaccinated for COVID — the initial shots, followed […]


FDA, Industry, Regulations, Vaccines

FDA delays decision on Moderna’s RSV vaccine

May 13, 2024

Via: Pharmaphorum

The company said the FDA would not be able to complete its review of the mRNA-1345 vaccine by the scheduled date of 12th May due to “administrative constraints”, causing nervousness among investors that led to a near-3% decline in its […]


Industry, Mergers and Acquisitions, Vaccines

Novavax gets a lifeline with Sanofi vaccine pact

May 10, 2024

Via: Biopharma Dive

Allying with Sanofi is a boost for Novavax, which has seen its share price crumble and come under activist investor pressure as it struggles to sell its COVID shot. The company pitched the vaccine as an alternative to the dominant […]


Industry, Vaccines

Painless Skin Patch Could Deliver Vaccines to Kids

April 30, 2024

Via: Drugs.com

Kids who don’t like vaccination shots might soon have an alternative in a painless skin patch, researchers say. More than 90% of 190 Gambian infants were protected from measles and all were protected from rubella after receiving a single vaccine […]


Industry, Vaccines

Vaccines Have Saved 154 Million Lives, Mostly Babies, Over Past 50 Years

April 29, 2024

Via: Drugs.com

Global vaccination efforts have saved an estimated 154 million lives, including 101 million infants, a new study led by the World Health Organization (WHO) shows. Immunization has contributed more to the health and survival of newborns than any other medical […]


Industry, Mergers and Acquisitions, Vaccines

CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines

April 19, 2024

Via: Pharma Times

CureVac and the University of Texas’s MD Anderson Cancer Center have announced a co-development and licensing agreement to develop novel messenger ribonucleic acid (mRNA)-based cancer vaccines. The strategic collaboration will focus on the development of differentiated cancer vaccine candidates in […]


Industry, Vaccines

The Path to a Better Tuberculosis Vaccine Runs Through Montana

April 18, 2024

Via: Kaiser Health News

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The BCG (Bacille Calmette-Guérin) vaccine, created in 1921, remains […]


Clinical Trials, Industry, Research and Development, Vaccines

Pfizer shares positive late-stage results for RSV vaccine Abrysvo in high-risk adults

April 10, 2024

Via: PMLiVE

RSV is a common contagious virus characterised by several mild, cold-like symptoms. Although most people recover within a week or two, the virus can cause severe illness in certain groups, including older adults, infants and those with certain underlying chronic […]


Industry, Mergers and Acquisitions, Vaccines

Univercells and Andelyn Biosciences Form Separate Drug Development Partnerships

April 3, 2024

Via: Biopharm International

On Mar. 25, 2024 Univercells announced a collaboration with Altamira Therapeutics, a producer of nanoparticle-based technology, under which Univercells will use Altamira’s SemaPhore nanoparticle platform to deliver messenger RNA (mRNA) vaccines. Also on Mar. 25, Andelyn Biosciences, a contract development […]


FDA, Industry, Regulations, Vaccines

Vaccines Protect You & Your Kids From Measles: FDA

March 4, 2024

Via: Drugs.com

As new outbreaks of measles — a once nearly eliminated illness in the United States — continue to emerge, experts remind Americans that there’s an easy way to stop infection: Get vaccinated. “Measles spreads so easily that if one person […]


Industry, Vaccines

Americans Have One Trusted Source for Info on COVID Vaccines

February 8, 2024

Via: Drugs.com

A doctor or nurse might be the only person capable of convincing a vaccine-hesitant person to get the COVID jab, a new study shows. Those who trust the medical profession are most likely to get vaccinated against COVID, despite their […]


Industry, Vaccines

Vaccines May Work Better if Arms Are Alternated for Each Shot

February 6, 2024

Via: Drugs.com

When getting vaccines, switching arms for each dose may produce greater immunity than having the jabs delivered into the same arm. That’s the finding from a new study that looked at the first two doses of COVID vaccines. Those who […]


Industry, Vaccines

Positive efficacy results for R21/Matrix-M malaria vaccine published in The Lancet

February 5, 2024

Via: PMLiVE

R21, which uses an adjuvant developed by Novavax to boost immune response, became the second malaria vaccine to be prequalified by the World Health Organization’s (WHO) in December 2023, following the organisation’s prequalification of the RTS,S/AS01 vaccine in July 2022. […]


Industry, Vaccines

NHS catch up campaign launched for missed MMR vaccines

January 22, 2024

Via: Pharma Times

The NHS has announced the launch of its new catch up campaign to get millions of children booked in for their missed measles, mumps and rubella (MMR) vaccine. The new campaign aligns with the health services efforts to protect children […]